Squarepoint
MDCO

Squarepoint’s Medicines Co MDCO Stock Holding History

Squarepoint’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,788
Closed -$3.21M – 2840
2019
Q4 		$3.21M Buy
+37,788
New +$2.52M 0.02% 658
2019
Q2 		– Sell
-42,987
Closed -$1.2M – 2805
2019
Q1 		$1.2M Buy
42,987
+4,717
+12% +$111K 0.01% 1008
2018
Q4 		$732K Buy
+38,270
New +$890K 0.01% 1050
2018
Q1 		– Sell
-119,785
Closed -$3.27M – 2381
2017
Q4 		$3.27M Buy
119,785
+102,006
+574% +$3.14M 0.06% 384
2017
Q3 		$659K Sell
17,779
-20,827
-54% -$768K 0.01% 874
2017
Q2 		$1.47M Buy
38,606
+33,929
+725% +$1.51M 0.03% 606
2017
Q1 		$229K Buy
+4,677
New +$213K 0.01% 1224
2016
Q4 		– Sell
-13,500
Closed -$509K – 1997
2016
Q3 		$509K Buy
+13,500
New +$509K 0.03% 553
2016
Q2 		– Sell
-48,925
Closed -$1.55M – 1443
2016
Q1 		$1.55M Buy
+48,925
New +$1.6M 0.12% 231

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Squarepoint's MDCO Position: Q1 2020 in Review

Squarepoint sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 37,788 shares — an estimated $3.21M sold.

Squarepoint first reported a position in MDCO in Q1 2016 and held it in 9 quarters. The position peaked at $3.27M in Q4 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Squarepoint reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Squarepoint sold 37,788 Medicines Co shares in Q1 2020, an estimated $3.21M.
  • Squarepoint first reported a position in Medicines Co in Q1 2016 and held it in 9 quarters.
  • Squarepoint's Medicines Co position peaked at $3.27M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Squarepoint's 13F filing for Q1 2020, filed 15 May 2020.